Skip to main content
HR 5278 108th Congress House Law Access to health care Administrative procedure Antitrust law Business records Commerce Consumer discounts Consumer education Consumer protection Contracts Damages Department of Health and Human Services Drug industry Drug utilization Drugs Employee health benefits Fees Finance and Financial Sector Financial statements Fines (Penalties)

Community Pharmacy Preservation Act of 2004

Introduced: October 7, 2004 See on congress.gov
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 25, 2004
Referred to the Subcommittee on Health.
Oct 8, 2004
Referred to the Subcommittee on Health.
Oct 7, 2004
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 7, 2004
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Community Pharmacy Preservation Act of 2004 - Provides that antitrust laws shall apply to negotiations between groups of independent pharmacies and health plans and health insurance issuers in the same manner as such laws apply to collective bargaining by labor organizations under the National Labor Relations Act.

Prohibits any pharmaceutical drug manufacturer from having a controlling interest in an entity that is a pharmacy benefit manager. Requires pharmacy benefit managers to disclose all compensation from drug manufacturers. Prohibits pharmacy benefit managers from making certain drug interchanges: (1) to a drug with a greater cost; (2) without disclosure to the individual; or (3) from a drug with generic equivalents to a drug without generic equivalents, unless the latter is lower in cost than each of the generic equivalents of the drug from which the prescription would be changed.

Directs the Secretary of Health and Human Services to apply specified standards for community pharmacy access under the Medicare outpatient prescription drug program.

What's happening now October 25, 2004

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5278: Community Pharmacy Preservation Act of 2004. 108th Congress. Open America. https://openamerica.io/bill/108-HR-5278/
MLA
"H.R. 5278: Community Pharmacy Preservation Act of 2004." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-5278/.
Bluebook (legal)
H.R. 5278, 108th Cong. (2026), https://openamerica.io/bill/108-HR-5278/.
Markdown link
[H.R. 5278: Community Pharmacy Preservation Act of 2004](https://openamerica.io/bill/108-HR-5278/)
Report a problem